Browse CRS Products

Filter

Topic

All

Abortion

Accounting & Auditing

Administrative Procedure Act (APA)

Affordable Care Act (ACA)

Afghanistan & Pakistan

Agency for Healthcare Research & Quality (AHRQ)

Agency for Toxic Substances & Disease Registry (ATSDR)

Agricultural Conservation Appropriations

Agricultural Technology & Research

Agricultural Trade

Agricultural Trade & Food Aid

Agriculture Appropriations

Agriculture Budget & Appropriations

Air & Missile Defense (AMD)

Air Quality

Air, Land, Sea, Space & Projection Forces

Alaska

Animal Agriculture

Appropriations

Appropriations Policy

Architect of the Capitol (AOC)

Arms Control & Nonproliferation

Artificial Intelligence

Asylees, Refugees & Other Humanitarian Concerns

Auditing Standards & Regulation

Aviation

Banking

Bankruptcy

Base Realignment & Closure (BRAC)

Biometrics

Biosafety & Biosecurity

Bolivia

Border Security

Border Security Between Ports of Entry

Border Security at Ports of Entry

Budget & Appropriations Procedure

Budget Reconciliation

Bureau of Indian Education (BIE)

Burial Benefits, National Cemeteries & Memorials

Business & Corporate Tax

Campaign Finance

Capital Gains Tax

Carbon Capture & Sequestration (CCS)

Career-Related Education & Training

Cash Assistance

Census

Center for Medicare and Medicaid Innovation (CMMI)

Central America

Central America and the Caribbean

Central Asian States

Charter Schools

Child Nutrition Programs

Child Support & Family Formation

Child Welfare

China

Civil Liberties & National Security

Civil Rights & Liberties

Clean Air Act (CAA)

Climate Change

Climate Change & Greenhouse Gas Control Legislation

Colleges & Universities

Colombia

Commemorations

Commerce, Justice, Science Appropriations

Commercial Space Industry

Commercial Space Policy

Committee Rules

Competition Policy & Law

Congressional Bill Introduction

Congressional Commissions

Congressional Committee Rules & Procedure

Congressional Committees

Congressional Communications, Publications & Documents

Congressional Ethics & Lobbying

Congressional Funding

Congressional Leadership

Congressional Operations

Conservation & Natural Resources

Consumer Credit Reporting

Consumer Finance Protection

Continuing Appropriations

Controlled Substances Act (CSA)

Corporation for National & Community Service (CNCS)

Crime

Criminal Justice

Criminal Justice Reform

Critical Infrastructure

Customs & Border Protection (CBP)

Cybercrime & Technology

Cybersecurity

DHS Structure & Management

Deep Fakes

Defense & Intelligence

Defense Acquisitions

Defense Appropriations

Defense Authorization

Defense Budgets & Appropriations

Defense Readiness, Training, Logistics & Installations

Deferred Action for Childhood Arrivals (DACA)

Author

All

Abigail A. Graber

Abigail F. Kolker

Abigail R. Overbay

Ada S. Cornell

Adam C. Nesbitt

Adam G. Levin

Adam K. Edgerton

Adam Stoll

Adam Vann

Adrienne L. Fernandes-Alcantara

Agata Bodie

Agata Dabrowska

Alejandra Aramayo

Alexa C. DeBoth

Alexander H. Pepper

Alexandra G. Neenan

Alexandra Hegji

Alexandria K. Mickler

Alexis Arieff

Alexis N. Boytim

Ali E. Lohman

Alice B. Grossman

Alice Y. Choi

Alicyn R. Gitlin

Alison M. Smith

Alison Mitchell

Alison Siskin

Alyse N. Minter

Alyssa K. King

Alyssa R. Casey

Amanda H. Peskin

Amanda K. Sarata

Amber D. Nair

Amber Hope Wilhelm

Andorra Bruno

Andrea M. Muto

Andreas Kuersten

Andres B. Schwarzenberg

Andrew Feickert

Andrew Nolan

Andrew P. Scott

Andrew S. Bowen

Andrew S. Coghlan

Andrew Tilghman

Angela C. Jones

Angela Napili

Angele A. Gilroy

Anita Regmi

Anna E. Normand

Anne A. Riddle

Anthony A. Cilluffo

Anthony R. Marshak

Anya L. Fink

April J. Anderson

Ashley J. Lawson

Audrey Celeste Crane-Hirsch

Audrey L. Singer

Audrey Singer

Baird Webel

Barbara L. Schwemle

Barbara Salazar Torreon

Barry F. Huston

Barry J. McMillion

Bart Elias

Ben Dolven

Ben Goldman

Ben Harrington

Ben Leubsdorf

Ben Wilhelm

Benjamin B. Wilhelm

Benjamin Collins

Benjamin Hayes

Benjamin M. Barczewski

Benjamin Tsui

Bernadette Fernandez

Betsy A. Cody

Bill Canis

Bill Heniff Jr.

Boris Granovskiy

Brandon J. Murrill

Brandon S. Tracy

Brendan McDermott

Brendan W. McGarry

Brent D. Yacobucci

Brian E. Humphreys

Brian T. Yeh

Bruce E. Foote

Bruce R. Lindsay

Bryan L. Adkins

Bryce H. P. Mendez

C. Stephen Redhead

Caitlin Campbell

Caitlin Curran

Caitlin Keating-Bitonti

Calvin Gibson

Cameron M. Keys

Carla Berry

Carla Y. Davis-Castro

Carly A. Miller

Carol Canada

Clear

Sort By

Title Date ↓ Type

Expiring Health Provisions of the 119th Congress

2025-09-24 · Reports · R48649 · HTML available · PDF available

Pharmaceutical Patent Disputes: Generic Entry for Small-Molecule Drugs Under the Hatch-Waxman Act

2025-06-12 · Resources · IF13028 · HTML available · PDF available

Pharmaceutical Patent Disputes: Biosimilar Entry Under the Biologics Price Competition and Innovation Act (BPCIA)

2025-06-12 · Resources · IF13029 · HTML available · PDF available

Most-Favored-Nation Prescription Drug Pricing Executive Order: Legal Issues

2025-06-05 · Posts · LSB11319 · HTML available · PDF available

Connecting Older Adults to Information on Benefits and Services

2025-06-03 · Reports · R47605 · HTML available · PDF available

U.S. Health Care Coverage and Spending

2025-02-19 · Resources · IF10830 · HTML available · PDF available

Medicare Part D Premium Stabilization Demonstration

2025-01-30 · Resources · IF12889 · HTML available · PDF available

“Skinny Labels” for Generic Drugs Under Hatch-Waxman

2024-12-27 · Resources · IF12700 · HTML available · PDF available

Administrative Procedure Act (APA) Challenges to the Medicare Drug Price Negotiation Program

2024-11-14 · Reports · R48264 · HTML available · PDF available

Federal Support for Organ Transplantation: Frequently Asked Questions

2024-11-08 · Reports · R48257 · HTML available · PDF available

Novel Gene Therapies for Blood Disorders

2024-10-25 · Resources · IF12796 · HTML available · PDF available

Constitutional Challenges to the Medicare Drug Price Negotiation Program

2024-10-10 · Reports · R47682 · HTML available · PDF available

Medicare Coverage of GLP-1 Drugs

2024-09-09 · Resources · IF12758 · HTML available · PDF available

State Regulation of Prescription Drug Prices: Prescription Drug Affordability Boards and Related Litigation

2024-09-04 · Posts · LSB11221 · HTML available · PDF available

Consolidated Appropriations Act, 2024 (P.L. 118-42): Medicaid and Medicare Provisions

2024-05-24 · Reports · R48075 · HTML available · PDF available

Litigation Continues Over Use of Contract Pharmacies in 340B Drug Discount Program

2024-05-23 · Posts · LSB11163 · HTML available · PDF available

Vanda Pharmaceuticals, Inc. v. United States: Fifth Amendment Takings Claims for Alleged Disclosures of Trade Secrets and Confidential Information

2024-04-08 · Posts · LSB11143 · HTML available · PDF available

Prescription Drug Importation

2024-01-22 · Resources · IF11056 · HTML available · PDF available

Pharmacy Benefit Managers: Current Legal Framework

2023-11-20 · Posts · LSB11080 · HTML available · PDF available

Medicare Part D Prescription Drug Benefit

2023-11-14 · Reports · R40611 · HTML available · PDF available

Medical Product Regulation: Drugs, Biologics, and Devices

2023-05-26 · Resources · IF11083 · HTML available · PDF available

Implementation of the Medicare Drug Price Negotiation Program: Centers for Medicare and Medicaid Guidance and Legal Considerations

2023-05-16 · Reports · R47555 · HTML available · PDF available

Insulin Coverage Under Private Health Insurance and Medicare Part D: In Brief

2023-02-06 · Reports · R47409 · HTML available · PDF available

Health Care Provisions of the Budget Reconciliation Measure P.L. 117-169

2023-01-24 · Reports · R47396 · HTML available · PDF available

Overview of the 340B Drug Discount Program

2022-10-14 · Resources · IF12232 · HTML available · PDF available

Courts Evaluate the Role of Contract Pharmacies in the 340B Drug Discount Program

2022-10-13 · Posts · LSB10842 · HTML available · PDF available

Supreme Court Overturns HHS Regulation Reducing the Medicare Outpatient Drug Reimbursement Rate for 340B Hospitals

2022-09-16 · Posts · LSB10821 · HTML available · PDF available

Prescription Drug Discount Coupons and Patient Assistance Programs (PAPs)

2022-09-12 · Reports · R44264 · HTML available · PDF available

Selected Health Provisions of the Inflation Reduction Act

2022-09-01 · Resources · IF12203 · HTML available · PDF available

Negotiation of Drug Prices in Medicare Part D

2022-05-23 · Resources · IF11318 · HTML available

Build Back Better Act (BBBA) Health Coverage Provisions: House-Passed and SenateReleased Language

2022-03-30 · Reports · R47056 · HTML available · PDF available

Frequently Asked Questions About Prescription Drug Pricing and Policy

2021-05-06 · Reports · R44832 · HTML available · PDF available

Expanded Access and Right to Try: Access to Investigational Drugs

2021-03-16 · Reports · R45414 · HTML available · PDF available

Off-Label Use of Prescription Drugs

2021-02-23 · Reports · R45792 · HTML available · PDF available

FDA’s Role in the Medical Product Supply Chain and Considerations During COVID-19

2020-09-01 · Reports · R46507 · HTML available · PDF available

Development and Regulation of Medical Countermeasures for COVID-19 (Vaccines, Diagnostics, and Treatments): Frequently Asked Questions

2020-06-25 · Reports · R46427 · HTML available · PDF available

Pharmaceutical Patenting Practices: A Legal Overview

2020-06-01 · Resources · IF11561 · HTML available · PDF available

Drug Price Disclosure to Consumers: Current Legal Authority and Considerations for Congress

2019-07-09 · Posts · LSB10323 · HTML available · PDF available

Biologics and Biosimilars: Background and Key Issues

2019-06-06 · Reports · R44620 · HTML available · PDF available

The Pharmaceutical Drug Development Process

2019-05-29 · Infographics · IG10013 · HTML available

Drug Pricing and the Law: Regulatory Exclusivities

2019-05-17 · Resources · IF11217 · HTML available · PDF available

FDA and Drug Prices: Facilitating Access to Generic Drugs

2019-01-17 · Resources · IF11075 · HTML available · PDF available

The SUPPORT for Patients and Communities Act (P.L.115-271): Medicare Provisions

2019-01-02 · Reports · R45449 · HTML available · PDF available

Drug Shortages: Causes, FDA Authority, and Policy Options

2018-12-27 · Resources · IF11058 · HTML available · PDF available

The SUPPORT for Patients and Communities Act (P.L. 115-271): Food and Drug Administration and Controlled Substance Provisions

2018-11-15 · Reports · R45405 · HTML available · PDF available

How FDA Approves Drugs and Regulates Their Safety and Effectiveness

2018-05-08 · Reports · R41983 · HTML available · PDF available

Prescription Drug User Fee Act (PDUFA): 2017 Reauthorization as PDUFA VI

2018-03-16 · Reports · R44864 · HTML available · PDF available

FDA Risk Evaluation and Mitigation Strategies (REMS): Description and Effect on Generic Drug Development

2018-03-16 · Reports · R44810 · HTML available · PDF available

Specialty Drugs: Background and Policy Concerns

2015-08-03 · Reports · R44132 · HTML available

Medicaid Prescription Drug Pricing and Policy

2014-11-07 · Reports · R43778 · HTML available